Diabetic Retinopathy

Latest News

CME Content

In-Person + Virtual Event

Retina Updates in Montréal

July 16-17, 2026

Video

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

Solange Peters, MD, PhD; Benjamin P. Levy, MD; Tony S.K. Mok, MD, BMSc, FRCP(C), FRCP(Edin), FHKCP, FHKAM(Medicine), FASCO; Maurice Pérol, MD

Video

PER Global Perspectives: Differentiating and Managing Toxicities with TROP2-Targeted ADCs in NSCLC Through Multidisciplinary Pathways

Solange Peters, MD, PhD; Stephanie McDonald, FNP-BC, AOCNP; Antonio Passaro, MD, PhD; Jacob Sands, MD

Video

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

SriniVas Sadda, MD, FARVO; Nathan Steinle, MD

Video

Interventional Dry Eye: A Stepwise Treatment & Management Approach

Mark Schaeffer, OD, FAAO; Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO, FAAOMS; Selina R. McGee, OD, FAAO

Video

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Mark R. Barakat, MD, FASRS; David Eichenbaum, MD, FASRS

Video

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

Dilsher Dhoot, MD, FASRS; Jordana G. Fein, MD, MS; Deep Parikh, MD; Xiao-Yi (Ellie) Zhou, MD

Video

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

Dante Pieramici, MD, FASRS; Dean Eliott, MD; Robin A. Vora, MD; Charles C. Wykoff, MD, PhD, FASRS

Video

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

Ramiro Maldonado, MD; Rebecca Nelson, MS, CGC; Robert A. Sisk, MD, FACS, FASRS

Video

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

David Almeida, MD, PhD, MBA; Margaret A. Chang, MD, MS; Arshad M. Khanani, MD, MA, FASRS; Jessica Randolph, MD

Video

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

SriniVas R. Sadda, MD, FARVO; Mark R. Barakat, MD, FASRS; David A. Eichenbaum, MD, FASRS

Video

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

Video

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

John Kitchens, MD; Michael W. Stewart, MD

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Dilsher S. Dhoot, MD, FASRS

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

Video

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO

Video

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

Screening DR + tele-ophthalmology AI: Less expensive than human assessment

ByLynda Charters

May 4th 2020

Determining risk of ocular damage from chronic intravitreal injections

ByLynda Charters

April 24th 2020

How autonomous diagnostics for DR gave a ‘jump-start’ to AI in ophthalmology

ByLynda Charters

March 30th 2020

Subthreshold laser may reduce intravitreal injections for DME

ByPauline T. Merrill, MD

March 3rd 2020

Connect the dots: Diagnosing, managing multifocal choroiditides

ByLynda Charters

January 31st 2020

Coming to terms with ‘ultra-widefield’ and ‘widefield’ imaging

January 7th 2020

Is deep learning the future of diabetic retinopathy screening?

ByMichelle Dalton, ELS

December 11th 2019

Tracking anti-VEGF use among Medicare Part B beneficiaries

ByMichelle Dalton, ELS

December 3rd 2019

Myopia may prove beneficial in preventing DR development

ByMichelle Dalton, ELS

November 18th 2019

Sustained DRSS improvement with aflibercept

ByMichelle Dalton, ELS

October 16th 2019

ASRS 2019 Street Team: Rishi P. Singh, MD

ByOT Staff Reports

August 28th 2019

ICYMI: Dr. Singh shares the take-home message from his 2019 presentation

ASRS 2019 Street Team: Charles C. Wykoff, MD, PhD

ByOT Staff Reports

August 28th 2019

ICMYI: Dr. Wykoff discusses results from his ASRS presentation

Anti-VEGFs pose no additional risk of SAEs over other therapies

ByMichelle Dalton, ELS

August 19th 2019

Retina risk app tool empowers diabetic patients worldwide

ByLynda Charters

August 1st 2019

Obesity + diabetic retinopathy: Korean study explores inverse association

ByLynda Charters

July 16th 2019

DNA analysis: Unraveling role of genetics in DR pathogenesis

ByLynda Charters

July 16th 2019

Lipid-lowering drugs, lower DR risk may go hand in hand

ByLynda Charters

July 1st 2019

Anti-VEGF expansion treats all DR stages

ByMichelle Dalton, ELS

June 14th 2019

Image-reading accuracy Increases with deep-learning DR algorithms

ByLynda Charters

May 14th 2019

UWF imaging contributes to earlier disease detection

ByRishi P. Singh, MD, FASRS

February 6th 2019

New research confirms agreement with 7 standard field imaging

Applying AI in fundus images

BySteve Lenier

February 5th 2019

FDA decision changes scope of healthcare delivery; increases patient access to early detection of DR

Micoaneurysm turnover in the early stages of diabetic retinopathy predicts how much the disease will progress, according to researchers.

Diabetic Retinopathy

Latest News

CME Content

Retina Updates in Montréal

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

PER Global Perspectives: Differentiating and Managing Toxicities with TROP2-Targeted ADCs in NSCLC Through Multidisciplinary Pathways

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Interventional Dry Eye: A Stepwise Treatment & Management Approach

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Screening DR + tele-ophthalmology AI: Less expensive than human assessment

Determining risk of ocular damage from chronic intravitreal injections

How autonomous diagnostics for DR gave a ‘jump-start’ to AI in ophthalmology

Subthreshold laser may reduce intravitreal injections for DME

Connect the dots: Diagnosing, managing multifocal choroiditides

Coming to terms with ‘ultra-widefield’ and ‘widefield’ imaging

Is deep learning the future of diabetic retinopathy screening?

Tracking anti-VEGF use among Medicare Part B beneficiaries

Myopia may prove beneficial in preventing DR development

Sustained DRSS improvement with aflibercept

ASRS 2019 Street Team: Rishi P. Singh, MD

ASRS 2019 Street Team: Charles C. Wykoff, MD, PhD

Anti-VEGFs pose no additional risk of SAEs over other therapies

Retina risk app tool empowers diabetic patients worldwide

Obesity + diabetic retinopathy: Korean study explores inverse association

DNA analysis: Unraveling role of genetics in DR pathogenesis

Lipid-lowering drugs, lower DR risk may go hand in hand

Anti-VEGF expansion treats all DR stages

Image-reading accuracy Increases with deep-learning DR algorithms

UWF imaging contributes to earlier disease detection

Applying AI in fundus images

Novel treatments in pipeline for diabetic eye disease

A study shows Alzheimer’s disease biomarkers in the vitreous

Anti-VEGFs can improve DRSS in majority of patients

Microaneurysm turnover predicts diabetic retinopathy progression

Trending on Eye Care Network - Ophthalmology Times

Port Delivery System Therapies in Retinal Vascular Diseases

Polyendocrine metabolic ovarian syndrome: looking past the reproductive system to the eye

Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study

NeuroOp Guru: What a big data study reveals about NAION and stroke risk

Safety Considerations in Retinal Vascular Diseases